Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.

The Global Info Research report includes an overview of the development of the Beta-Nicotinamide Mononucleotide (NMN) industry chain, the market status of Health Care Products (Content Greater than or Equal to 98%, Content Less than 98%), Cosmetics (Content Greater than or Equal to 98%, Content Less than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Beta-Nicotinamide Mononucleotide (NMN).

Regionally, the report analyzes the Beta-Nicotinamide Mononucleotide (NMN) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Beta-Nicotinamide Mononucleotide (NMN) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Beta-Nicotinamide Mononucleotide (NMN) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Beta-Nicotinamide Mononucleotide (NMN) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Content Greater than or Equal to 98%, Content Less than 98%).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Beta-Nicotinamide Mononucleotide (NMN) market.

Regional Analysis: The report involves examining the Beta-Nicotinamide Mononucleotide (NMN) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Beta-Nicotinamide Mononucleotide (NMN) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Beta-Nicotinamide Mononucleotide (NMN):

Company Analysis: Report covers individual Beta-Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Beta-Nicotinamide Mononucleotide (NMN) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Care Products, Cosmetics).

Technology Analysis: Report covers specific technologies relevant to Beta-Nicotinamide Mononucleotide (NMN). It assesses the current state, advancements, and potential future developments in Beta-Nicotinamide Mononucleotide (NMN) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Beta-Nicotinamide Mononucleotide (NMN) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Beta-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Content Greater than or Equal to 98%
Content Less than 98%

Market segment by Application
Health Care Products
Cosmetics
Others

Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Beta-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide (NMN) from 2018 to 2023.

Chapter 3, the Beta-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Beta-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide (NMN).

Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.